OpiCalc Logo

OpiCalc

927 Clinical Tools

Logo
OpiCalc
7-Point Dermoscopy ChecklistABSI (Burn Severity)AGEP ScoreAJCC Melanoma StagingALDEN AlgorithmBWH SCC StagingBody Surface Area (BSA)Breslow & Clark MicrostagingCTCAE Skin ToxicityDLQIEASI ScoreGAGS (Acne)HiSCRIGAIHS4Lund-Browder ChartMSK Melanoma NomogramMelanoma Risk ScreeningPASI ScorePOEMParkland FormulaRegiSCAR DRESS ValidationRevised Baux ScoreSCORADSCORTENmPASI
OpiCalc Logo

OpiCalc

Open-access clinical infrastructure. Built to the standard every clinician deserves — fast, private, and free.

Zero data stored
Always free
Our mission & transparency

Get in Touch

Tool request, clinical feedback, or partnership inquiry — we read everything.

WhatsApp feedback
Email us
Partnership inquiry

© 2026 OpiCalc • Calculated Care

MissionPrivacyTerms

Body Surface Area (BSA)

Body Surface Area (BSA): Essential for dosing of dermatological therapeutics and quantitative assessment of dermatoses extent. Formula used: Mosteller.
Guidelines & Evidence

Clinical Details

Section 1

When to Use

When to Use

Estimating the extent of cutaneous involvement for rashes, psoriasis, or burns.
Determining the feasibility of topical vs. systemic treatment.
Burn management triage (though Rule of Nines is faster, BSA estimation using the Palm method is more precise for scattered lesions).
Section 2

Formula & Logic

Methods of Calculation

Palm Method: The patient’s hand (including the fingers) represents approximately 1% of their total body surface area.
Palmar Surface: The palm alone (excluding fingers) is roughly 0.5% BSA.
Rule of Nines: Divides body into 9% blocks (e.g., each leg 18%, thorax 18%, abdomen 18%). Better for large contiguous areas like burns.
Section 3

Pearls/Pitfalls

Clinical Pearls

Always use the PATIENT'S hand size, not the examiner's hand size, to estimate 1%.
Overestimation is very common in psoriasis; spacing out plaques conceptually into a solid block helps visualize true BSA.
Section 4

Next Steps

Interpretation bounds (Psoriasis)

< 3% BSA: Mild disease. Generally managed with topicals.
3-10% BSA: Moderate disease. May require phototherapy or systemic oral agents.
> 10% BSA: Severe disease. Candidacy for biologic therapy is strongly considered.
Section 5

Evidence Appraisal

Last Comprehensive Review: 2026

Related Dermatology Tools

7-Point Dermoscopy Checklist
ABSI
AGEP Score
AJCC Melanoma Staging
ALDEN Algorithm
Breslow & Clark Microstaging
BWH SCC Staging
CTCAE Skin Toxicity
DLQI
EASI Score
Have feedback about this calculator?Let us know.